1
|
Bessa MJ, Sarmento B, Oliveira M, Rodrigues F. In vitro data for fire pollutants: contribution of studies using human cell models towards firefighters' occupational. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH. PART B, CRITICAL REVIEWS 2023; 26:238-255. [PMID: 36883725 DOI: 10.1080/10937404.2023.2187909] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/18/2023]
Abstract
Firefighters are the principal line of defense against fires, being at elevated risk of exposure to health-relevant pollutants released during fires and burning processes. Although many biomonitoring studies exist, only a limited number of human in vitro investigations in fire risk assessment are currently available. In vitro studies stand out as valuable tools to assess the toxicity mechanisms involved following exposure to fire pollutants at a cellular level. The aim of the present review was to contextualize existing in vitro studies using human cell models exposed to chemicals emitted from fire emissions and wood smoke and discuss the implications of the observed toxic outcomes on adverse health effects detected in firefighters. Most of the reported in vitro investigations focused on monocultures respiratory models and exposure to particulate matter (PM) extracts collected from fire effluents. Overall, (1) a decrease in cellular viability, (2) enhanced oxidative stress, (3) increased pro-inflammatory cytokines levels and (4) elevated cell death frequencies were noted. However, limited information remains regarding the toxicity mechanisms initiated by firefighting activities. Hence, more studies employing advanced in vitro models and exposure systems using human cell lines are urgently needed taking into consideration different routes of exposure and health-related pollutants released from fires. Data are needed to establish and define firefighters' occupational exposure limits and to propose mitigation strategies to promote beneficial human health.
Collapse
Affiliation(s)
- Maria João Bessa
- UNIPRO - Unidade de Investigação em Patologia e Reabilitação Oral, Instituto Universitário de Ciências da Saúde (IUCS), CESPU, Gandra, Portugal
| | - Bruno Sarmento
- UNIPRO - Unidade de Investigação em Patologia e Reabilitação Oral, Instituto Universitário de Ciências da Saúde (IUCS), CESPU, Gandra, Portugal
- i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal
- INEB - Institute of Biomedical Engineering, University of Porto, Porto, Portugal
| | - Marta Oliveira
- REQUIMTE/LAQV, ISEP, Polytechnique of Porto, Porto, Portugal
| | | |
Collapse
|
2
|
Corsi I, Venditti I, Trotta F, Punta C. Environmental safety of nanotechnologies: The eco-design of manufactured nanomaterials for environmental remediation. THE SCIENCE OF THE TOTAL ENVIRONMENT 2023; 864:161181. [PMID: 36581299 DOI: 10.1016/j.scitotenv.2022.161181] [Citation(s) in RCA: 16] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Revised: 12/09/2022] [Accepted: 12/21/2022] [Indexed: 06/17/2023]
Abstract
Nanosafety is paramount considering the risks associated with manufactured nanomaterials (MNMs) whose implications could outweigh their advantages for environmental applications. Although nanotechnology-based solutions to implement pollution control, remediation and prevention are incremental with clear benefits for public health and Earth' natural ecosystems, nanoremediation is having a setback due to the risks associated with the safety of MNMs for humans and the environment. MNMs are diverse, work differently and bionano-interactions occurring upon environmental exposure will guide their fate and hazardous outcomes. Here we propose a new ecologically-based design strategy (eco-design) having its roots in green nanoscience and LCA that will ground on an Ecological Risk Assessment approach, which introduces the evaluation of MNMs' ecotoxicity along with their performances and efficacies at the design stage. As such, the proposed eco-design strategy will allow recognition and design-out since the very beginning of material synthesis, those hazardous peculiar features that can be hazardous to living beings and the natural environment. A more ecologically sound eco-design strategy in which nanosafety is conceptually included in MNMs design will sustain safer nanotechnologies including those for the environment as remediation by leveraging any risks for humans and natural ecosystems.
Collapse
Affiliation(s)
- Ilaria Corsi
- Department of Physical, Earth and Environmental Sciences, University of Siena, via Mattioli, 4, 53100 Siena, Italy.
| | - Iole Venditti
- Department of Sciences, Roma Tre University of Rome, via della Vasca Navale 79, 00146 Rome, Italy
| | - Francesco Trotta
- Department of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy
| | - Carlo Punta
- Department of Chemistry, Materials, and Chemical Engineering "G. Natta" and INSTM Local Unit, Politecnico di Milano, Piazza Leonardo da Vinci 32, I-20133 Milano, Italy
| |
Collapse
|
3
|
Oladipo AO, Lebelo SL, Msagati TAM. Nanocarrier design–function relationship: The prodigious role of properties in regulating biocompatibility for drug delivery applications. Chem Biol Interact 2023; 377:110466. [PMID: 37004951 DOI: 10.1016/j.cbi.2023.110466] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Revised: 03/14/2023] [Accepted: 03/28/2023] [Indexed: 04/03/2023]
Abstract
The concept of drug delivery systems as a magic bullet for the delivery of bioactive compounds has emerged as a promising approach in the treatment of different diseases with significant advantages over the limitations of traditional methods. While nanocarrier-based drug delivery systems are the main advocates of drug uptake because they offer several advantages including reduced non-specific biodistribution, improved accumulation, and enhanced therapeutic efficiency; their safety and biocompatibility within cellular/tissue systems are therefore important for achieving the desired effect. The underlying power of "design-interplay chemistry" in modulating the properties and biocompatibility at the nanoscale level will direct the interaction with their immediate surrounding. Apart from improving the existing nanoparticle physicochemical properties, the balancing of the hosts' blood components interaction holds the prospect of conferring newer functions altogether. So far, this concept has been remarkable in achieving many fascinating feats in addressing many challenges in nanomedicine such as immune responses, inflammation, biospecific targeting and treatment, and so on. This review, therefore, provides a diverse account of the recent advances in the fabrication of biocompatible nano-drug delivery platforms for chemotherapeutic applications, as well as combination therapy, theragnostic, and other diseases that are of interest to scientists in the pharmaceutical industries. Thus, careful consideration of the "property of choice" would be an ideal way to realize specific functions from a set of delivery platforms. Looking ahead, there is an enormous prospect for nanoparticle properties in regulating biocompatibility.
Collapse
Affiliation(s)
- Adewale O Oladipo
- Department of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa, Private Bag X06, Florida, 1710, South Africa.
| | - Sogolo L Lebelo
- Department of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa, Private Bag X06, Florida, 1710, South Africa
| | - Titus A M Msagati
- Institute for Nanotechnology and Water Sustainability (iNanoWS), College of Science, Engineering, and Technology, University of South Africa, Private Bag X06, Florida, 1710, South Africa
| |
Collapse
|
4
|
McLean P, Mueller W, Gosens I, Cassee FR, Rothen-Rutishauser B, Boyles M, Tran L. Establishing relationships between particle-induced in vitro and in vivo inflammation endpoints to better extrapolate between in vitro markers and in vivo fibrosis. Part Fibre Toxicol 2023; 20:5. [PMID: 36759844 PMCID: PMC9909881 DOI: 10.1186/s12989-023-00516-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2022] [Accepted: 02/01/2023] [Indexed: 02/11/2023] Open
Abstract
BACKGROUND Toxicity assessment for regulatory purposes is starting to move away from traditional in vivo methods and towards new approach methodologies (NAM) such as high-throughput in vitro models and computational tools. For materials with limited hazard information, utilising quantitative Adverse Outcome Pathways (AOPs) in a testing strategy involving NAM can produce information relevant for risk assessment. The aim of this work was to determine the feasibility of linking in vitro endpoints to in vivo events, and moreover to key events associated with the onset of a chosen adverse outcome to aid in the development of NAM testing strategies. To do this, we focussed on the adverse outcome pathway (AOP) relating to the onset of pulmonary fibrosis. RESULTS We extracted in vivo and in vitro dose-response information for particles known to induce this pulmonary fibrosis (crystalline silica, specifically α-quartz). To test the in vivo-in vitro extrapolation (IVIVE) determined for crystalline silica, cerium dioxide nanoparticles (nano-CeO2) were used as a case study allowing us to evaluate our findings with a less studied substance. The IVIVE methodology outlined in this paper is formed of five steps, which can be more generally summarised into two categories (i) aligning the in vivo and in vitro dosimetry, (ii) comparing the dose-response curves and derivation of conversion factors. CONCLUSION Our analysis shows promising results with regards to correlation of in vitro cytokine secretion to in vivo acute pulmonary inflammation assessed by polymorphonuclear leukocyte influx, most notable is the potential of using IL-6 and IL-1β cytokine secretion from simple in vitro submerged models as a screening tool to assess the likelihood of lung inflammation at an early stage in product development, hence allowing a more targeted investigation using either a smaller, more targeted in vivo study or in the future a more complex in vitro protocol. This paper also highlights the strengths and limitations as well as the current difficulties in performing IVIVE assessment and suggestions for overcoming these issues.
Collapse
Affiliation(s)
- Polly McLean
- Institute of Occupational Medicine (IOM), Edinburgh, UK.
| | - William Mueller
- grid.410343.10000 0001 2224 0230Institute of Occupational Medicine (IOM), Edinburgh, UK
| | - Ilse Gosens
- grid.31147.300000 0001 2208 0118National Institute for Public Health and the Environment – RIVM, Bilthoven, The Netherlands
| | - Flemming R. Cassee
- grid.31147.300000 0001 2208 0118National Institute for Public Health and the Environment – RIVM, Bilthoven, The Netherlands ,grid.5477.10000000120346234Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Barbara Rothen-Rutishauser
- grid.8534.a0000 0004 0478 1713Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland
| | - Matthew Boyles
- grid.410343.10000 0001 2224 0230Institute of Occupational Medicine (IOM), Edinburgh, UK
| | - Lang Tran
- grid.410343.10000 0001 2224 0230Institute of Occupational Medicine (IOM), Edinburgh, UK
| |
Collapse
|
5
|
Wang T, Meng Z, Liu L, Li W. Insights into the interaction between cadmium/tetracycline and nano-TiO 2 on a zeolite surface. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH INTERNATIONAL 2023; 30:18522-18534. [PMID: 36215003 DOI: 10.1007/s11356-022-23482-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/01/2022] [Accepted: 10/03/2022] [Indexed: 06/16/2023]
Abstract
Titanium dioxide (TiO2) nanoparticles interact with organic-inorganic pollutants in the environment, and these interactions affect their environmental behavior. The mechanisms of the interaction between TiO2 and organic-inorganic pollutants on the surface of clay minerals are still unclear. In this work, isotherm adsorption was studied to explore the interactions between Cd2+/tetracycline (TC), TiO2 nanoparticles, and a zeolite (Zeo). SEM, FT-IR, and XPS were also used to reveal the interaction mechanism between organic-inorganic pollutants and TiO2 on their stability and mobility in the environment. Compared to the single systems, the adsorption of Cd2+ and TiO2 in the Cd + TiO2 composite system decreased by 3.43% and 9.90%, respectively; the TC and TiO2 adsorption in the TC + TiO2 composite system decreased by 14.39% and 45.47%, respectively. The antagonism between Cd2+ and TiO2 was due to Cd2+ and TiO2 competing for the electrostatic attraction (-OH) and hydrogen bonding sites (Si-O), and TC and TiO2 competing for the hydrogen bonding sites (-OH and C = O) on Zeo. The presence of TiO2 will increase the mobility of Cd2+ and TC on a clay surface, and this effect is more significant for organic pollutants TC. Compared with Cd2+, TC has a more significant boosting impact on the TiO2 mobility.
Collapse
Affiliation(s)
- Teng Wang
- College of Natural Resources and Environment, Northwest A&F University, Yangling, 712100, Shaanxi Province, People's Republic of China.
- Department of Life Sciences, Changzhi University, Changzhi, 046011, People's Republic of China.
| | - Zhaofu Meng
- College of Natural Resources and Environment, Northwest A&F University, Yangling, 712100, Shaanxi Province, People's Republic of China
- Key Lab of Nutrition and Agro-Environment in Northwest China, Ministry of Agriculture, Yangling, 712100, People's Republic of China
| | - Lin Liu
- Department of Life Sciences, Changzhi University, Changzhi, 046011, People's Republic of China
| | - Wenbin Li
- College of Environmental Science and Engineering, China West Normal University, Nanchong, Sichuan, 637009, People's Republic of China
| |
Collapse
|
6
|
Lin Z, Aryal S, Cheng YH, Gesquiere AJ. Integration of In Vitro and In Vivo Models to Predict Cellular and Tissue Dosimetry of Nanomaterials Using Physiologically Based Pharmacokinetic Modeling. ACS NANO 2022; 16:19722-19754. [PMID: 36520546 PMCID: PMC9798869 DOI: 10.1021/acsnano.2c07312] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
Nanomaterials (NMs) have been increasingly used in a number of areas, including consumer products and nanomedicine. Target tissue dosimetry is important in the evaluation of safety, efficacy, and potential toxicity of NMs. Current evaluation of NM efficacy and safety involves the time-consuming collection of pharmacokinetic and toxicity data in animals and is usually completed one material at a time. This traditional approach no longer meets the demand of the explosive growth of NM-based products. There is an emerging need to develop methods that can help design safe and effective NMs in an efficient manner. In this review article, we critically evaluate existing studies on in vivo pharmacokinetic properties, in vitro cellular uptake and release and kinetic modeling, and whole-body physiologically based pharmacokinetic (PBPK) modeling studies of different NMs. Methods on how to simulate in vitro cellular uptake and release kinetics and how to extrapolate cellular and tissue dosimetry of NMs from in vitro to in vivo via PBPK modeling are discussed. We also share our perspectives on the current challenges and future directions of in vivo pharmacokinetic studies, in vitro cellular uptake and kinetic modeling, and whole-body PBPK modeling studies for NMs. Finally, we propose a nanomaterial in vitro to in vivo extrapolation via physiologically based pharmacokinetic modeling (Nano-IVIVE-PBPK) framework for high-throughput screening of target cellular and tissue dosimetry as well as potential toxicity of different NMs in order to meet the demand of efficient evaluation of the safety, efficacy, and potential toxicity of a rapidly increasing number of NM-based products.
Collapse
Affiliation(s)
- Zhoumeng Lin
- Department
of Environmental and Global Health, College of Public Health and Health
Professions, University of Florida, Gainesville, Florida 32610, United States
- Center
for
Environmental and Human Toxicology, University
of Florida, Gainesville, Florida 32608, United
States
| | - Santosh Aryal
- Department
of Pharmaceutical Sciences and Health Outcomes, The Ben and Maytee
Fisch College of Pharmacy, The University
of Texas at Tyler, Tyler, Texas 75799, United States
| | - Yi-Hsien Cheng
- Department
of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas 66506, United States
- Institute
of Computational Comparative Medicine, Kansas
State University, Manhattan, Kansas 66506, United States
| | - Andre J. Gesquiere
- Department
of Chemistry, College of Sciences, University
of Central Florida, Orlando, Florida 32816, United States
- NanoScience
Technology Center, University of Central
Florida, Orlando, Florida 32826, United States
- Department
of Materials Science and Engineering, College of Engineering,, University of Central Florida, Orlando, Florida 32816, United States
| |
Collapse
|
7
|
Koterov AN. Causal Criteria in Medical and Biological Disciplines: History, Essence, and Radiation Aspect. Report 3, Part 2: Hill’s Last Four Criteria: Use and Limitations. BIOL BULL+ 2022. [DOI: 10.1134/s1062359022110115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
|
8
|
Cheimarios N, Pem B, Tsoumanis A, Ilić K, Vrček IV, Melagraki G, Bitounis D, Isigonis P, Dusinska M, Lynch I, Demokritou P, Afantitis A. An In Vitro Dosimetry Tool for the Numerical Transport Modeling of Engineered Nanomaterials Powered by the Enalos RiskGONE Cloud Platform. NANOMATERIALS (BASEL, SWITZERLAND) 2022; 12:3935. [PMID: 36432221 PMCID: PMC9697428 DOI: 10.3390/nano12223935] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/22/2022] [Revised: 10/29/2022] [Accepted: 11/01/2022] [Indexed: 06/16/2023]
Abstract
A freely available "in vitro dosimetry" web application is presented enabling users to predict the concentration of nanomaterials reaching the cell surface, and therefore available for attachment and internalization, from initial dispersion concentrations. The web application is based on the distorted grid (DG) model for the dispersion of engineered nanoparticles (NPs) in culture medium used for in vitro cellular experiments, in accordance with previously published protocols for cellular dosimetry determination. A series of in vitro experiments for six different NPs, with Ag and Au cores, are performed to demonstrate the convenience of the web application for calculation of exposure concentrations of NPs. Our results show that the exposure concentrations at the cell surface can be more than 30 times higher compared to the nominal or dispersed concentrations, depending on the NPs' properties and their behavior in the cell culture medium. Therefore, the importance of calculating the exposure concentration at the bottom of the cell culture wells used for in vitro arrays, i.e., the particle concentration at the cell surface, is clearly presented, and the tool introduced here allows users easy access to such calculations. Widespread application of this web tool will increase the reliability of subsequent toxicity data, allowing improved correlation of the real exposure concentration with the observed toxicity, enabling the hazard potentials of different NPs to be compared on a more robust basis.
Collapse
Affiliation(s)
| | - Barbara Pem
- Institute for Medical Research and Occupational Health, 10 000 Zagreb, Croatia
| | | | - Krunoslav Ilić
- Institute for Medical Research and Occupational Health, 10 000 Zagreb, Croatia
| | | | | | - Dimitrios Bitounis
- Center for Nanotechnology and Nanotoxicology, HSPH-NIEHS Nanosafety Research Center, Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, USA
| | - Panagiotis Isigonis
- Department of Environmental Sciences, Informatics and Statistics, Ca’ Foscari University of Venice, 30172 Venice, Italy
| | - Maria Dusinska
- Department of Environmental Chemistry, Health Effects Laboratory, NILU—Norwegian Institute for Air Research, 2007 Kjeller, Norway
| | - Iseult Lynch
- School of Geography, Earth and Environmental Sciences, University of Birmingham, Birmingham B15 2TT, UK
| | - Philip Demokritou
- Center for Nanotechnology and Nanotoxicology, HSPH-NIEHS Nanosafety Research Center, Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, USA
| | | |
Collapse
|
9
|
Romeo D, Hischier R, Nowack B, Wick P. Approach toward In Vitro-Based Human Toxicity Effect Factors for the Life Cycle Impact Assessment of Inhaled Low-Solubility Particles. ENVIRONMENTAL SCIENCE & TECHNOLOGY 2022; 56:8552-8560. [PMID: 35657801 PMCID: PMC9227749 DOI: 10.1021/acs.est.2c01816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Revised: 05/18/2022] [Accepted: 05/18/2022] [Indexed: 06/15/2023]
Abstract
Today's scarcity of animal toxicological data for nanomaterials could be lifted by substituting in vivo data with in vitro data to calculate nanomaterials' effect factors (EF) for Life Cycle Assessment (LCA). Here, we present a step-by-step procedure to calculate in vitro-to-in vivo extrapolation factors to estimate human Benchmark Doses and subsequently in vitro-based EFs for several inhaled nonsoluble nanomaterials. Based on mouse data, the in vitro-based EF of TiO2 is between 2.76 · 10-4 and 1.10 · 10-3 cases/(m2/g·kg intake), depending on the aerodynamic size of the particle, which is in good agreement with in vivo-based EFs (1.51 · 10-4-5.6 · 10-2 cases/(m2/g·kg intake)). The EF for amorphous silica is in a similar range as for TiO2, but the result is less robust due to only few in vivo data available. The results based on rat data are very different, confirming the importance of selecting animal species representative of human responses. The discrepancy between in vivo and in vitro animal data in terms of availability and quality limits the coverage of further nanomaterials. Systematic testing on human and animal cells is needed to reduce the variability in toxicological response determined by the differences in experimental conditions, thus helping improve the predictivity of in vitro-to-in vivo extrapolation factors.
Collapse
Affiliation(s)
- Daina Romeo
- Particles-Biology
Interactions Laboratory, Empa, Swiss Federal
Laboratories for Materials Science and Technology, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland
| | - Roland Hischier
- Technology and Society Laboratory, Empa, Swiss Federal Laboratories for Materials Science and
Technology, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland
| | - Bernd Nowack
- Technology and Society Laboratory, Empa, Swiss Federal Laboratories for Materials Science and
Technology, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland
| | - Peter Wick
- Particles-Biology
Interactions Laboratory, Empa, Swiss Federal
Laboratories for Materials Science and Technology, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland
| |
Collapse
|
10
|
Jagiello K, Ciura K. In vitro to in vivo extrapolation to support the development of the next generation risk assessment (NGRA) strategy for nanomaterials. NANOSCALE 2022; 14:6735-6742. [PMID: 35446334 DOI: 10.1039/d2nr00664b] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
There is growing interest in developing novel strategies to support assessment of human health risks due to chemicals. Regulatory and decision-making agencies have recommended that non-animal-based alternatives should be applied whenever possible instead of experimentation on living animals. These alternative methods are beneficial because they are ethical, inexpensive, and rapid. Herein, we review recent activities aimed at developing in vitro to in vivo extrapolation (IVIVE) models as a part of the Next Generation Risk Assessment (NGRA) of nanomaterials. In this context, we show the adverse outcome pathway (AOP)-based methodology for the identification of mechanistically relevant events serving as biomarkers for the targeted selection of in vitro assays. Considered events need to be biologically plausible, regulatory relevant, and crucial for the examination of occurrence of adverse outcomes. The promising advantages of using high-throughout-based omics data are highlighted. Furthermore, the application of 3D in vitro models and nano genome atlases to study nanoparticle toxicity is briefly summarized. Additionally, the challenges related to the extrapolation of in vitro doses into in vivo-relevant responses are presented. We also discuss the limitations of models applied thus far to study the fate of chemicals in the human body, which exist due to the lack of available knowledge regarding transformations of nanomaterials occurring in biological systems.
Collapse
Affiliation(s)
- Karolina Jagiello
- QSAR Lab Ltd., Trzy Lipy 3, 80-172 Gdansk, Poland.
- University of Gdansk, Faculty of Chemistry, Wita Stwosza 63, 80-308 Gdansk, Poland
| | - Krzesimir Ciura
- QSAR Lab Ltd., Trzy Lipy 3, 80-172 Gdansk, Poland.
- Medical University of Gdansk, Faculty of Pharmacy, Department of Physical Chemistry, J. Hallera Avenue 107, 80-416, Gdansk, Poland
| |
Collapse
|
11
|
Forest V. Experimental and Computational Nanotoxicology-Complementary Approaches for Nanomaterial Hazard Assessment. NANOMATERIALS 2022; 12:nano12081346. [PMID: 35458054 PMCID: PMC9031966 DOI: 10.3390/nano12081346] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/17/2022] [Revised: 04/07/2022] [Accepted: 04/12/2022] [Indexed: 12/25/2022]
Abstract
The growing development and applications of nanomaterials lead to an increasing release of these materials in the environment. The adverse effects they may elicit on ecosystems or human health are not always fully characterized. Such potential toxicity must be carefully assessed with the underlying mechanisms elucidated. To that purpose, different approaches can be used. First, experimental toxicology consisting of conducting in vitro or in vivo experiments (including clinical studies) can be used to evaluate the nanomaterial hazard. It can rely on variable models (more or less complex), allowing the investigation of different biological endpoints. The respective advantages and limitations of in vitro and in vivo models are discussed as well as some issues associated with experimental nanotoxicology. Perspectives of future developments in the field are also proposed. Second, computational nanotoxicology, i.e., in silico approaches, can be used to predict nanomaterial toxicity. In this context, we describe the general principles, advantages, and limitations especially of quantitative structure–activity relationship (QSAR) models and grouping/read-across approaches. The aim of this review is to provide an overview of these different approaches based on examples and highlight their complementarity.
Collapse
Affiliation(s)
- Valérie Forest
- Mines Saint-Etienne, Univ Lyon, Univ Jean Monnet, Etablissement Français du Sang, INSERM, U1059 Sainbiose, Centre CIS, F-42023 Saint-Etienne, France
| |
Collapse
|
12
|
Doak SH, Clift MJD, Costa A, Delmaar C, Gosens I, Halappanavar S, Kelly S, Pejinenburg WJGM, Rothen-Rutishauser B, Schins RPF, Stone V, Tran L, Vijver MG, Vogel U, Wohlleben W, Cassee FR. The Road to Achieving the European Commission's Chemicals Strategy for Nanomaterial Sustainability-A PATROLS Perspective on New Approach Methodologies. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2022; 18:e2200231. [PMID: 35324067 DOI: 10.1002/smll.202200231] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/12/2022] [Revised: 02/17/2022] [Indexed: 06/14/2023]
Abstract
The European Green Deal outlines ambitions to build a more sustainable, climate neutral, and circular economy by 2050. To achieve this, the European Commission has published the Chemicals Strategy for Sustainability: Towards a Toxic-Free Environment, which provides targets for innovation to better protect human and environmental health, including challenges posed by hazardous chemicals and animal testing. The European project PATROLS (Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment) has addressed multiple aspects of the Chemicals Strategy for Sustainability by establishing a battery of new approach methodologies, including physiologically anchored human and environmental hazard assessment tools to evaluate the safety of engineered nanomaterials. PATROLS has delivered and improved innovative tools to support regulatory decision-making processes. These tools also support the need for reducing regulated vertebrate animal testing; when used at an early stage of the innovation pipeline, the PATROLS tools facilitate the safe and sustainable development of new nano-enabled products before they reach the market.
Collapse
Affiliation(s)
- Shareen H Doak
- Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK
| | - Martin J D Clift
- Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK
| | - Anna Costa
- Institute of Science and Technology for Ceramics, CNR-ISTEC-National Research Council of Italy, Faenza, Italy
| | - Christiaan Delmaar
- National Institute for Public Health and the Environment Netherlands, PO box 1, Bilthoven, 3720, the Netherlands
| | - Ilse Gosens
- National Institute for Public Health and the Environment Netherlands, PO box 1, Bilthoven, 3720, the Netherlands
| | - Sabina Halappanavar
- Environmental Health Science and Research Bureau, Health Canada, Ottawa, K1A0K9, Canada
| | - Sean Kelly
- Nanotechnology Industries Association, Avenue Tervueren 143, Brussels, 1150, Belgium
| | - Willie J G M Pejinenburg
- National Institute for Public Health and the Environment Netherlands, PO box 1, Bilthoven, 3720, the Netherlands
- Leiden University, PO Box 9518, Leiden, 2300 RA, the Netherlands
| | | | - Roel P F Schins
- IUF-Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225, Düsseldorf, Germany
| | - Vicki Stone
- School of Engineering and Physical Sciences, Heriot Watt University, Edinburgh, UK
| | - Lang Tran
- Institute of Occupational Medicine (IOM), Edinburgh, Scotland, EH14 4AP, UK
| | - Martina G Vijver
- Leiden University, PO Box 9518, Leiden, 2300 RA, the Netherlands
| | - Ulla Vogel
- National Research Centre for the Working Environment, Copenhagen, DK-2100, Denmark
| | - Wendel Wohlleben
- Advanced Materials Research, BASF SE, 67056, Ludwigshafen, Germany
| | - Flemming R Cassee
- National Institute for Public Health and the Environment Netherlands, PO box 1, Bilthoven, 3720, the Netherlands
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| |
Collapse
|
13
|
McCarrick S, Karlsson HL, Carlander U. Modelled lung deposition and retention of welding fume particles in occupational scenarios: a comparison to doses used in vitro. Arch Toxicol 2022; 96:969-985. [PMID: 35188583 PMCID: PMC8921161 DOI: 10.1007/s00204-022-03247-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Accepted: 02/02/2022] [Indexed: 11/25/2022]
Abstract
Translating particle dose from in vitro systems to relevant human exposure remains a major challenge for the use of in vitro studies in assessing occupational hazard and risk of particle exposure. This study aimed to model the lung deposition and retention of welding fume particles following occupational scenarios and subsequently compare the lung doses to those used in vitro. We reviewed published welding fume concentrations and size distributions to identify input values simulating real-life exposure scenarios in the multiple path particle dosimetry (MPPD) model. The majority of the particles were reported to be below 0.1 μm and mass concentrations ranged between 0.05 and 45 mg/m3. Following 6-h exposure to 5 mg/m3 with a count median diameter of 50 nm, the tracheobronchial lung dose (0.89 µg/cm2) was found to exceed the in vitro cytotoxic cell dose (0.125 µg/cm2) previously assessed by us in human bronchial epithelial cells (HBEC-3kt). However, the tracheobronchial retention decreased rapidly when no exposure occurred, in contrast to the alveolar retention which builds-up over time and exceeded the in vitro cytotoxic cell dose after 1.5 working week. After 1 year, the tracheobronchial and alveolar retention was estimated to be 1.15 and 2.85 µg/cm2, respectively. Exposure to low-end aerosol concentrations resulted in alveolar retention comparable to cytotoxic in vitro dose in HBEC-3kt after 15-20 years of welding. This study demonstrates the potential of combining real-life exposure data with particle deposition modelling to improve the understanding of in vitro concentrations in the context of human occupational exposure.
Collapse
Affiliation(s)
- Sarah McCarrick
- Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.
| | - Hanna L Karlsson
- Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden
| | - Ulrika Carlander
- Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden
| |
Collapse
|
14
|
Collection of Controlled Nanosafety Data—The CoCoN-Database, a Tool to Assess Nanomaterial Hazard. NANOMATERIALS 2022; 12:nano12030441. [PMID: 35159786 PMCID: PMC8839907 DOI: 10.3390/nano12030441] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/09/2021] [Revised: 01/22/2022] [Accepted: 01/24/2022] [Indexed: 12/23/2022]
Abstract
Hazard assessment is the first step in nanomaterial risk assessment. The overall number of studies on the biological effects of nanomaterials or innovative materials is steadily increasing and is above 40,000. Several databases have been established to make the amount of data manageable, but these are often highly specialized or can be used only by experts. This paper describes a new database which uses an already existing data collection of about 35,000 publications. The collection from the first phase between the years 2000 and 2013 contains about 11,000 articles and this number has been reduced by specific selection criteria. The resulting publications have been evaluated for their quality regarding the toxicological content and the experimental data have been extracted. In addition to material properties, the most important value to be extracted is the no-observed-adverse-effect-level (NOAEL) for in vivo and the no-observed-effect-concentration (NOEC) for in vitro studies. The correlation of the NOAEL/NOEC values with the nanomaterial properties and the investigated endpoints has been tested in projects such as the OECD-AOP project, where the available data for inflammatory responses have been analysed. In addition, special attention was paid to titanium dioxide particles and this example is used to show with searches for in vitro and in vivo experiments on possible lung toxicity what a typical result of a database query can look like. In this review, an emerging database is described that contains valuable information for nanomaterial hazard estimation and should aid in the progress of nanosafety research.
Collapse
|
15
|
Use of an in silico knowledge discovery approach to determine mechanistic studies of silver nanoparticles-induced toxicity from in vitro to in vivo. Part Fibre Toxicol 2022; 19:6. [PMID: 35031062 PMCID: PMC8759195 DOI: 10.1186/s12989-022-00447-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2021] [Accepted: 12/29/2021] [Indexed: 12/11/2022] Open
Abstract
Background Silver nanoparticles (AgNPs) are considered a double-edged sword that demonstrates beneficial and harmful effects depending on their dimensions and surface coating types. However, mechanistic understanding of the size- and coating-dependent effects of AgNPs in vitro and in vivo remains elusive. We adopted an in silico decision tree-based knowledge-discovery-in-databases process to prioritize the factors affecting the toxic potential of AgNPs, which included exposure dose, cell type and AgNP type (i.e., size and surface coating), and exposure time. This approach also contributed to effective knowledge integration between cell-based phenomenological observations and in vitro/in vivo mechanistic explorations. Results The consolidated cell viability assessment results were used to create a tree model for generalizing cytotoxic behavior of the four AgNP types: SCS, LCS, SAS, and LAS. The model ranked the toxicity-related parameters in the following order of importance: exposure dose > cell type > particle size > exposure time ≥ surface coating. Mechanistically, larger AgNPs appeared to provoke greater levels of autophagy in vitro, which occurred during the earlier phase of both subcytotoxic and cytotoxic exposures. Furthermore, apoptosis rather than necrosis majorly accounted for compromised cell survival over the above dosage range. Intriguingly, exposure to non-cytotoxic doses of AgNPs induced G2/M cell cycle arrest and senescence instead. At the organismal level, SCS following a single intraperitoneal injection was found more toxic to BALB/c mice as compared to SAS. Both particles could be deposited in various target organs (e.g., spleen, liver, and kidneys). Morphological observation, along with serum biochemical and histological analyses, indicated that AgNPs could produce pancreatic toxicity, apart from leading to hepatic inflammation. Conclusions Our integrated in vitro, in silico, and in vivo study revealed that AgNPs exerted toxicity in dose-, cell/organ type- and particle type-dependent manners. More importantly, a single injection of lethal-dose AgNPs (i.e., SCS and SAS) could incur severe damage to pancreas and raise blood glucose levels at the early phase of exposure. Supplementary Information The online version contains supplementary material available at 10.1186/s12989-022-00447-0.
Collapse
|
16
|
Elberskirch L, Binder K, Riefler N, Sofranko A, Liebing J, Minella CB, Mädler L, Razum M, van Thriel C, Unfried K, Schins RPF, Kraegeloh A. Digital research data: from analysis of existing standards to a scientific foundation for a modular metadata schema in nanosafety. Part Fibre Toxicol 2022; 19:1. [PMID: 34983569 PMCID: PMC8728981 DOI: 10.1186/s12989-021-00442-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2021] [Accepted: 12/16/2021] [Indexed: 12/11/2022] Open
Abstract
BACKGROUND Assessing the safety of engineered nanomaterials (ENMs) is an interdisciplinary and complex process producing huge amounts of information and data. To make such data and metadata reusable for researchers, manufacturers, and regulatory authorities, there is an urgent need to record and provide this information in a structured, harmonized, and digitized way. RESULTS This study aimed to identify appropriate description standards and quality criteria for the special use in nanosafety. There are many existing standards and guidelines designed for collecting data and metadata, ranging from regulatory guidelines to specific databases. Most of them are incomplete or not specifically designed for ENM research. However, by merging the content of several existing standards and guidelines, a basic catalogue of descriptive information and quality criteria was generated. In an iterative process, our interdisciplinary team identified deficits and added missing information into a comprehensive schema. Subsequently, this overview was externally evaluated by a panel of experts during a workshop. This whole process resulted in a minimum information table (MIT), specifying necessary minimum information to be provided along with experimental results on effects of ENMs in the biological context in a flexible and modular manner. The MIT is divided into six modules: general information, material information, biological model information, exposure information, endpoint read out information and analysis and statistics. These modules are further partitioned into module subdivisions serving to include more detailed information. A comparison with existing ontologies, which also aim to electronically collect data and metadata on nanosafety studies, showed that the newly developed MIT exhibits a higher level of detail compared to those existing schemas, making it more usable to prevent gaps in the communication of information. CONCLUSION Implementing the requirements of the MIT into e.g., electronic lab notebooks (ELNs) would make the collection of all necessary data and metadata a daily routine and thereby would improve the reproducibility and reusability of experiments. Furthermore, this approach is particularly beneficial regarding the rapidly expanding developments and applications of novel non-animal alternative testing methods.
Collapse
Affiliation(s)
- Linda Elberskirch
- INM - Leibniz Institute for New Materials, Campus D2 2, 66123, Saarbrücken, Germany
| | - Kunigunde Binder
- FIZ Karlsruhe - Leibniz Institute for Information Infrastructure, Hermann-von-Helmholtz-Platz 1, 76133, Eggenstein-Leopoldshafen, Germany
| | - Norbert Riefler
- IWT - Leibniz-Institut für Werkstofforientierte Technologien, Badgasteiner Str. 3, 28359, Bremen, Germany
| | - Adriana Sofranko
- IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225, Düsseldorf, Germany
| | - Julia Liebing
- IfADo - Leibniz Research Centre for Working Environment and Human Factors, Ardeystraße 67, 44139, Dortmund, Germany
| | - Christian Bonatto Minella
- FIZ Karlsruhe - Leibniz Institute for Information Infrastructure, Hermann-von-Helmholtz-Platz 1, 76133, Eggenstein-Leopoldshafen, Germany
| | - Lutz Mädler
- IWT - Leibniz-Institut für Werkstofforientierte Technologien, Badgasteiner Str. 3, 28359, Bremen, Germany
| | - Matthias Razum
- FIZ Karlsruhe - Leibniz Institute for Information Infrastructure, Hermann-von-Helmholtz-Platz 1, 76133, Eggenstein-Leopoldshafen, Germany
| | - Christoph van Thriel
- IfADo - Leibniz Research Centre for Working Environment and Human Factors, Ardeystraße 67, 44139, Dortmund, Germany
| | - Klaus Unfried
- IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225, Düsseldorf, Germany
| | - Roel P F Schins
- IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225, Düsseldorf, Germany
| | - Annette Kraegeloh
- INM - Leibniz Institute for New Materials, Campus D2 2, 66123, Saarbrücken, Germany.
| |
Collapse
|
17
|
Overview of Adverse Outcome Pathways and Current Applications on Nanomaterials. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2022; 1357:415-439. [DOI: 10.1007/978-3-030-88071-2_17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
18
|
Gouin T, Ellis-Hutchings R, Thornton Hampton LM, Lemieux CL, Wright SL. Screening and prioritization of nano- and microplastic particle toxicity studies for evaluating human health risks - development and application of a toxicity study assessment tool. MICROPLASTICS AND NANOPLASTICS 2022; 2:2. [PMID: 35098152 PMCID: PMC8760192 DOI: 10.1186/s43591-021-00023-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/10/2021] [Accepted: 12/13/2021] [Indexed: 05/23/2023]
Abstract
UNLABELLED Concern regarding the human health implications that exposure to nano- and microplastic particles (NMPs) potentially represents is increasing. While there have been several years of research reporting on the ecotoxicological effects of NMPs, human health toxicology studies have only recently emerged. The available human health hazard data are thus limited, with potential concern regarding the relevance and reliability for understanding the potential human health implications. In this study we develop and apply a NMP toxicity screening assessment tool (NMP-TSAT) for evaluating human health effects studies against a suite of quality assurance and quality control (QA/QC) criteria for both in vivo and in vitro studies. A total of 74 studies representing either inhalation or oral exposure pathways were identified and evaluated. Assessment categories include particle characterization, experimental design, and applicability for risk assessment; with critical and non-critical criteria organized to allow screening and prioritization. It is observed that the majority of studies evaluated using the NMP-TSAT have been performed on monodisperse particles, predominately spheres (≈60%), consisting of polystyrene (≈46%). The majority of studies have tested particles < 5 μm, with a minimal particle size of 10 nm and a maximum particle size of about 200 μm. The total assessment score (TAS) possible for in vivo studies is 52, whereas for in vitro studies it is 46, which is based on receiving a maximum score of 2 against 26 and 23 criteria, respectively. The evaluated TAS ranged from between 12 and 44 and 16-34, for in vivo and in vitro studies, respectively. Given the challenges associated with prioritizing studies based on ranking them according to their TAS we propose a Tiered approach, whereby studies are initially screened based on how they score against various critical criteria, which have been defined for their relevance for assessing the hazards and risks for human health. In this instance, studies that score a minimum of '1' against each of the critical criteria, regardless of how they rank according to their TAS, are prioritized as part of a Tier 1 screening and prioritization phase, which would then be followed by an expert evaluation, representing a Tier 2 level of assessment. Using this approach we identify 10 oral ingestion and 2 inhalation studies that score at least 1 against all critical criteria. Lastly, several key observations for strengthening future effects studies are identified, these include a need for the generation and access to standard reference materials representative of human exposure to NMPs for use in toxicity test systems and/or the improved characterization and verification of test particle characteristics, and the adoption of study design guidance, such as recommended by OECD, when conducting either in vivo inhalation or oral ingestion toxicity tests. SUPPLEMENTARY INFORMATION The online version contains supplementary material available at 10.1186/s43591-021-00023-x.
Collapse
Affiliation(s)
- Todd Gouin
- TG Environmental Research, Sharnbrook, Bedfordshire, UK
| | - Robert Ellis-Hutchings
- Toxicology and Environmental Research & Consulting, The Dow Chemical Company, Midland, MI 48673 USA
| | - Leah M. Thornton Hampton
- Department of Toxicology, Southern California Coastal Water Research Project, Costa Mesa, CA USA
| | - Christine L. Lemieux
- Air Quality and Risk Assessment Division, Water and Air Quality Bureau, Health Canada, Ottawa, ON K1A 0K9 Canada
| | - Stephanie L. Wright
- Environmental Research Group, School of Public Health, Imperial College London, Sir Michael Uren Hub, 86 Wood Lane, London, W12 0BZ UK
| |
Collapse
|
19
|
Romeo D, Nowack B, Wick P. Combined in vitro-in vivo dosimetry enables the extrapolation of in vitro doses to human exposure levels: A proof of concept based on a meta-analysis of in vitro and in vivo titanium dioxide toxicity data. NANOIMPACT 2022; 25:100376. [PMID: 35559882 DOI: 10.1016/j.impact.2021.100376] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/09/2021] [Revised: 12/10/2021] [Accepted: 12/10/2021] [Indexed: 05/27/2023]
Abstract
Evaluating the potential risks of nanomaterials on human health is fundamental to assure their safety. To do so, Human Health Risk Assessment (HHRA) relies mostly on animal studies to provide information about nanomaterials toxicity. The scarcity of such data, due to the shift of the nanotoxicology field away from a phenomenological, animal-based approach and towards a mechanistic understanding based on in vitro studies, represents a challenge for HHRA. Implementing in vitro data in the HHRA methodology requires an extrapolation strategy; combining in vitro dosimetry and lung dosimetry can be an option to estimate the toxic effects on lung cells caused by inhaled nanomaterials. Since the two dosimetry models have rarely been used together, we developed a combined dosimetry model (CoDo) that estimates the air concentrations corresponding to the in vitro doses, extrapolating in this way in vitro doses to human doses. Applying the model to a data set of in vitro and in vivo toxicity data about titanium dioxide, we demonstrated CoDo's multiple applications. First, we confirmed that most in vitro doses are much higher than realistic human exposures, considering the Swiss Occupational Exposure Limit as benchmark. The comparison of the Benchmark Doses (BMD) extrapolated from in vitro and in vivo data, using the surface area dose metric, showed that despite both types of data had a quite wide range, animal data were overall more precise. The high variability of the results may be due both to the dis-homogeneity of the original data (different cell lines, particle properties, etc.) and to the high level of uncertainty in the extrapolation procedure caused by both model assumptions and experimental conditions. Moreover, while the surface area BMDs from studies on rodents and rodent cells were comparable, human co-cultures showed less susceptibility and had higher BMDs regardless of the titanium dioxide type. Last, a Support Vector Machine classification model built on the in vitro data set was able to predict the BMD-derived human exposure level range for viability effects based on the particle properties and experimental conditions with an accuracy of 85%, while for cytokine release in vitro and neutrophil influx in vivo the model had a lower performance.
Collapse
Affiliation(s)
- Daina Romeo
- Empa, Swiss Federal Laboratories for Materials Science and Technology, Particles-Biology Interactions Laboratory, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland.
| | - Bernd Nowack
- Empa, Swiss Federal Laboratories for Materials Science and Technology, Technology and Society Laboratory, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland.
| | - Peter Wick
- Empa, Swiss Federal Laboratories for Materials Science and Technology, Particles-Biology Interactions Laboratory, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland.
| |
Collapse
|
20
|
Coffin S, Bouwmeester H, Brander S, Damdimopoulou P, Gouin T, Hermabessiere L, Khan E, Koelmans AA, Lemieux CL, Teerds K, Wagner M, Weisberg SB, Wright S. Development and application of a health-based framework for informing regulatory action in relation to exposure of microplastic particles in California drinking water. MICROPLASTICS AND NANOPLASTICS 2022; 2:12. [PMID: 35634037 PMCID: PMC9132802 DOI: 10.1186/s43591-022-00030-6] [Citation(s) in RCA: 18] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/24/2021] [Accepted: 03/11/2022] [Indexed: 05/06/2023]
Abstract
UNLABELLED Microplastics have been documented in drinking water, but their effects on human health from ingestion, or the concentrations at which those effects begin to manifest, are not established. Here, we report on the outcome of a virtual expert workshop conducted between October 2020 and October 2021 in which a comprehensive review of mammalian hazard studies was conducted. A key objective of this assessment was to evaluate the feasibility and confidence in deriving a human health-based threshold value to inform development of the State of California's monitoring and management strategy for microplastics in drinking water. A tiered approach was adopted to evaluate the quality and reliability of studies identified from a review of the peer-reviewed scientific literature. A total of 41 in vitro and 31 in vivo studies using mammals were identified and subjected to a Tier 1 screening and prioritization exercise, which was based on an evaluation of how each of the studies addressed various quality criteria. Prioritized studies were identified largely based on their application and reporting of dose-response relationships. Given that methods for extrapolating between in vitro and in vivo systems are currently lacking, only oral exposure in vivo studies were identified as fit-for-purpose within the context of this workshop. Twelve mammalian toxicity studies were prioritized and subjected to a Tier 2 qualitative evaluation by external experts. Of the 12 studies, 7 report adverse effects on male and female reproductive systems, while 5 reported effects on various other physiological endpoints. It is notable that the majority of studies (83%) subjected to Tier 2 evaluation report results from exposure to a single polymer type (polystyrene spheres), representing a size range of 0.040 to 20 µm. No single study met all desired quality criteria, but collectively toxicological effects with respect to biomarkers of inflammation and oxidative stress represented a consistent trend. While it was possible to derive a conservative screening level to inform monitoring activities, it was not possible to extrapolate a human-health-based threshold value for microplastics, which is largely due to concerns regarding the relative quality and reliability of current data, but also due to the inability to extrapolate data from studies using monodisperse plastic particles, such as polystyrene spheres to an environmentally relevant exposure of microplastics. Nevertheless, a conservative screening level value was used to estimate a volume of drinking water (1000 L) that could be used to support monitoring activities and improve our overall understanding of exposure in California's drinking water. In order to increase confidence in our ability to derive a human-health-based threshold value in the future, several research recommendations are provided, with an emphasis towards strengthening how toxicity studies should be conducted in the future and an improved understanding of human exposure to microplastics, insights critically important to better inform future risk assessments. SUPPLEMENTARY INFORMATION The online version contains supplementary material available at 10.1186/s43591-022-00030-6.
Collapse
Affiliation(s)
- Scott Coffin
- California State Water Resources Control Board, Sacramento, CA USA
| | - Hans Bouwmeester
- Division of Toxicology, Wageningen University & Research, Wageningen, Netherlands
| | - Susanne Brander
- Fisheries, Wildlife, and Conservation Sciences Dept, Coastal Oregon Marine Experiment Station, Oregon State University, Newport, OR USA
| | - Pauliina Damdimopoulou
- Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden
| | - Todd Gouin
- TG Environmental Research, Sharnbrook, MK44 1PL UK
| | - Ludovic Hermabessiere
- Department of Ecology and Evolutionary Biology, University of Toronto, Toronto, ON Canada
| | - Elaine Khan
- California Office of Environmental Health and Hazard Assessment, Sacramento, CA USA
| | - Albert A. Koelmans
- Aquatic Ecology and Water Quality Management Group, Wageningen University & Research, Wageningen, Netherlands
| | - Christine L. Lemieux
- Safe Environments Directorate, Health Canada, Water and Air Quality Bureau, Ottawa, ON Canada
| | - Katja Teerds
- Department of Animal Sciences, Human and Animal Physiology, Wageningen University & Research, Wageningen, Netherlands
| | - Martin Wagner
- Norwegian University of Science & Technology, Trondheim, Norway
| | | | - Stephanie Wright
- Environmental Research Group, School of Public Health, Imperial College London, Sir Michael Uren Hub, 86 Wood Lane, London, W12 0BZ UK
| |
Collapse
|
21
|
Nizam NUM, Hanafiah MM, Woon KS. A Content Review of Life Cycle Assessment of Nanomaterials: Current Practices, Challenges, and Future Prospects. NANOMATERIALS 2021; 11:nano11123324. [PMID: 34947673 PMCID: PMC8708326 DOI: 10.3390/nano11123324] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/07/2021] [Revised: 11/30/2021] [Accepted: 12/03/2021] [Indexed: 11/27/2022]
Abstract
This paper provides a comprehensive review of 71 previous studies on the life cycle assessment (LCA) of nanomaterials (NMs) from 2001 to 2020 (19 years). Although various studies have been carried out to assess the efficiency and potential of wastes for nanotechnology, little attention has been paid to conducting a comprehensive analysis related to the environmental performance and hotspot of NMs, based on LCA methodology. Therefore, this paper highlights and discusses LCA methodology’s basis (goal and scope definition, system boundary, life cycle inventory, life cycle impact assessment, and interpretation) to insights into current practices, limitations, progress, and challenges of LCA application NMs. We found that there is still a lack of comprehensive LCA study on the environmental impacts of NMs until end-of-life stages, thereby potentially supporting misleading conclusions, in most of the previous studies reviewed. For a comprehensive evaluation of LCA of NMs, we recommend that future studies should: (1) report more detailed and transparent LCI data within NMs LCA studies; (2) consider the environmental impacts and potential risks of NMs within their whole life cycle; (3) adopt a transparent and prudent characterization model; and (4) include toxicity, uncertainty, and sensitivity assessments to analyze the exposure pathways of NMs further. Future recommendations towards improvement and harmonization of methodological for future research directions were discussed and provided. This study’s findings redound to future research in the field of LCA NMs specifically, considering that the release of NMs into the environment is yet to be explored due to limited understanding of the mechanisms and pathways involved.
Collapse
Affiliation(s)
- Nurul Umairah M. Nizam
- Department of Earth Sciences and Environment, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, Malaysia;
| | - Marlia M. Hanafiah
- Department of Earth Sciences and Environment, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, Malaysia;
- Centre for Tropical Climate Change System, Institute of Climate Change, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, Malaysia
- Correspondence:
| | - Kok Sin Woon
- School of Energy and Chemical Engineering, Xiamen University Malaysia, Jalan Sunsuria, Bandar Sunsuria, Sepang 43900, Selangor, Malaysia;
| |
Collapse
|
22
|
Rossner P, Cervena T, Vojtisek-Lom M. In vitro exposure to complete engine emissions - a mini-review. Toxicology 2021; 462:152953. [PMID: 34537260 DOI: 10.1016/j.tox.2021.152953] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2021] [Revised: 08/14/2021] [Accepted: 09/13/2021] [Indexed: 10/20/2022]
Abstract
Outdoor air pollution is classified as carcinogenic to humans and exposure to it contributes to increased incidence of various diseases, including cardiovascular, neurological or pulmonary disorders. Vehicle engine emissions represent a significant part of outdoor air pollutants, particularly in large cities with high population density. Considering the potentially negative health impacts of engine emissions exposure, the application of reliable test systems allowing assessment of the biological effects of these pollutants is crucial. The exposure systems should use relevant, preferably multicellular, cell models that are treated with the complete engine exhaust (i.e. a realistic mixture of particles, chemical compounds bound to them and gaseous phase) at the air-liquid interface. The controlled delivery and characterization of chemical and/or particle composition of the exhaust should be possible. In this mini-review we report on such exposure systems that have been developed to date. We focus on a brief description and technical characterization of the systems, and discuss the biological parameters detected following exposure to a gasoline/diesel exhaust. Finally, we summarize and compare findings from the individual systems, including their advantages/limitations.
Collapse
Affiliation(s)
- Pavel Rossner
- Department of Nanotoxicology and Molecular Epidemiology, Institute of Experimental Medicine of the CAS, Videnska 1083, 142 20, Prague, Czech Republic.
| | - Tereza Cervena
- Department of Nanotoxicology and Molecular Epidemiology, Institute of Experimental Medicine of the CAS, Videnska 1083, 142 20, Prague, Czech Republic
| | - Michal Vojtisek-Lom
- Centre of Vehicles for Sustainable Mobility, Faculty of Mechanical Engineering, Czech Technical University in Prague, Technicka 4, 160 00, Prague, Czech Republic
| |
Collapse
|
23
|
More S, Bampidis V, Benford D, Bragard C, Halldorsson T, Hernández‐Jerez A, Hougaard Bennekou S, Koutsoumanis K, Lambré C, Machera K, Naegeli H, Nielsen S, Schlatter J, Schrenk D, Silano (deceased) V, Turck D, Younes M, Castenmiller J, Chaudhry Q, Cubadda F, Franz R, Gott D, Mast J, Mortensen A, Oomen AG, Weigel S, Barthelemy E, Rincon A, Tarazona J, Schoonjans R. Guidance on risk assessment of nanomaterials to be applied in the food and feed chain: human and animal health. EFSA J 2021; 19:e06768. [PMID: 34377190 PMCID: PMC8331059 DOI: 10.2903/j.efsa.2021.6768] [Citation(s) in RCA: 55] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/30/2021] [Indexed: 02/08/2023] Open
Abstract
The EFSA has updated the Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain, human and animal health. It covers the application areas within EFSA's remit, including novel foods, food contact materials, food/feed additives and pesticides. The updated guidance, now Scientific Committee Guidance on nano risk assessment (SC Guidance on Nano-RA), has taken account of relevant scientific studies that provide insights to physico-chemical properties, exposure assessment and hazard characterisation of nanomaterials and areas of applicability. Together with the accompanying Guidance on Technical requirements for regulated food and feed product applications to establish the presence of small particles including nanoparticles (Guidance on Particle-TR), the SC Guidance on Nano-RA specifically elaborates on physico-chemical characterisation, key parameters that should be measured, methods and techniques that can be used for characterisation of nanomaterials and their determination in complex matrices. The SC Guidance on Nano-RA also details aspects relating to exposure assessment and hazard identification and characterisation. In particular, nanospecific considerations relating to in vitro/in vivo toxicological studies are discussed and a tiered framework for toxicological testing is outlined. Furthermore, in vitro degradation, toxicokinetics, genotoxicity, local and systemic toxicity as well as general issues relating to testing of nanomaterials are described. Depending on the initial tier results, additional studies may be needed to investigate reproductive and developmental toxicity, chronic toxicity and carcinogenicity, immunotoxicity and allergenicity, neurotoxicity, effects on gut microbiome and endocrine activity. The possible use of read-across to fill data gaps as well as the potential use of integrated testing strategies and the knowledge of modes or mechanisms of action are also discussed. The Guidance proposes approaches to risk characterisation and uncertainty analysis.
Collapse
|
24
|
Toxicity of Carbon Nanomaterials-Towards Reliable Viability Assessment via New Approach in Flow Cytometry. Int J Mol Sci 2021; 22:ijms22147750. [PMID: 34299367 PMCID: PMC8305450 DOI: 10.3390/ijms22147750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Revised: 07/12/2021] [Accepted: 07/14/2021] [Indexed: 11/25/2022] Open
Abstract
The scope of application of carbon nanomaterials in biomedical, environmental and industrial fields is recently substantially increasing. Since in vitro toxicity testing is the first essential step for any commercial usage, it is crucial to have a reliable method to analyze the potentially harmful effects of carbon nanomaterials. Even though researchers already reported the interference of carbon nanomaterials with common toxicity assays, there is still, unfortunately, a large number of studies that neglect this fact. In this study, we investigated interference of four bio-promising carbon nanomaterials (graphene acid (GA), cyanographene (GCN), graphitic carbon nitride (g-C3N4) and carbon dots (QCDs)) in commonly used LIVE/DEAD assay. When a standard procedure was applied, materials caused various types of interference. While positively charged g-C3N4 and QCDs induced false results through the creation of free agglomerates and intrinsic fluorescence properties, negatively charged GA and GCN led to false signals due to the complex quenching effect of the fluorescent dye of a LIVE/DEAD kit. Thus, we developed a new approach using a specific gating strategy based on additional controls that successfully overcame all types of interference and lead to reliable results in LIVE/DEAD assay. We suggest that the newly developed procedure should be a mandatory tool for all in vitro flow cytometry assays of any class of carbon nanomaterials.
Collapse
|
25
|
Mitrano DM, Wick P, Nowack B. Placing nanoplastics in the context of global plastic pollution. NATURE NANOTECHNOLOGY 2021; 16:491-500. [PMID: 33927363 DOI: 10.1038/s41565-021-00888-2] [Citation(s) in RCA: 209] [Impact Index Per Article: 69.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/18/2020] [Accepted: 03/03/2021] [Indexed: 05/13/2023]
Abstract
Numerous studies have made the ubiquitous presence of plastic in the environment undeniable, and thus it no longer comes as a surprise when scientists measure the accumulation of macroplastic litter and microplastic fragments in both urban and remote sites. Nanoplastics have recently emerged in the discussions of scientists, regulators and the public, as the weathering of macroplastics may lead to a substantial burden of nanoplastics in various ecosystems. While nanoplastics particles themselves have not (yet) been extensively measured in the environment, there is increased concern that this size fraction of plastic may be more extensively distributed and hazardous that larger-sized particles. This assessment may emanate from an unease with the term 'nano', which may elicit a negative response over uncertainties of the pervasiveness of nanoplastics specifically, or from the lessons learned by many years of intensive environmental health and safety research of engineered nanomaterials. Ultimately, the different physical and chemical characteristics of the different size classes of plastic pollution (macroplastics, microplastics and nanoplastics) will result in divergent fate and hazards. As nanoscientists specializing in understanding the fate, transport and interactions of nanoparticles in human and environmental systems, in this Perspective, we try to place nanoplastics in the context of global plastic pollution by assessing its sources and risks, and by assessing commonalities nanoplastics may share with other nanosized objects in environmental systems, such as engineered nanomaterials and natural colloids.
Collapse
Affiliation(s)
- Denise M Mitrano
- Department of Environmental Systems Science, ETH Zurich, Zurich, Switzerland.
| | - Peter Wick
- Particles-Biology Interactions Laboratory, Empa - Swiss Federal Laboratories for Materials Science and Technology, St. Gallen, Switzerland
| | - Bernd Nowack
- Technology and Society Laboratory, Empa - Swiss Federal Laboratories for Materials Science and Technology, St. Gallen, Switzerland
| |
Collapse
|
26
|
Albalawi F, Hussein MZ, Fakurazi S, Masarudin MJ. Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines. Int J Nanomedicine 2021; 16:161-184. [PMID: 33447033 PMCID: PMC7802788 DOI: 10.2147/ijn.s288236] [Citation(s) in RCA: 32] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2020] [Accepted: 12/05/2020] [Indexed: 12/14/2022] Open
Abstract
The emergence of nanotechnology as a key enabling technology over the past years has opened avenues for new and innovative applications in nanomedicine. From the business aspect, the nanomedicine market was estimated to worth USD 293.1 billion by 2022 with a perception of market growth to USD 350.8 billion in 2025. Despite these opportunities, the underlying challenges for the future of engineered nanomaterials (ENMs) in nanomedicine research became a significant obstacle in bringing ENMs into clinical stages. These challenges include the capability to design bias-free methods in evaluating ENMs' toxicity due to the lack of suitable detection and inconsistent characterization techniques. Therefore, in this literature review, the state-of-the-art of engineered nanomaterials in nanomedicine, their toxicology issues, the working framework in developing a toxicology benchmark and technical characterization techniques in determining the toxicity of ENMs from the reported literature are explored.
Collapse
Affiliation(s)
- Fahad Albalawi
- Department of Medical Laboratory and Blood Bank, King Fahad Specialist Hospital-Tabuk, Tabuk, Saudi Arabia
- Materials Synthesis and Characterization Laboratory, Institute of Advanced Technology (ITMA), Universiti Putra Malaysia, Serdang, Selangor, Malaysia
| | - Mohd Zobir Hussein
- Materials Synthesis and Characterization Laboratory, Institute of Advanced Technology (ITMA), Universiti Putra Malaysia, Serdang, Selangor, Malaysia
| | - Sharida Fakurazi
- Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia
- Natural Medicine and Product Research Laboratory Institute of Bioscience, Serdang, Selangor, Malaysia
| | - Mas Jaffri Masarudin
- Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia
| |
Collapse
|
27
|
Leibrock LB, Jungnickel H, Tentschert J, Katz A, Toman B, Petersen EJ, Bierkandt FS, Singh AV, Laux P, Luch A. Parametric Optimization of an Air-Liquid Interface System for Flow-Through Inhalation Exposure to Nanoparticles: Assessing Dosimetry and Intracellular Uptake of CeO 2 Nanoparticles. NANOMATERIALS (BASEL, SWITZERLAND) 2020; 10:E2369. [PMID: 33260672 PMCID: PMC7760223 DOI: 10.3390/nano10122369] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/03/2020] [Revised: 11/26/2020] [Accepted: 11/27/2020] [Indexed: 12/11/2022]
Abstract
Air-liquid interface (ALI) systems have been widely used in recent years to investigate the inhalation toxicity of many gaseous compounds, chemicals, and nanomaterials and represent an emerging and promising in vitro method to supplement in vivo studies. ALI exposure reflects the physiological conditions of the deep lung more closely to subacute in vivo inhalation scenarios compared to submerged exposure. The comparability of the toxicological results obtained from in vivo and in vitro inhalation data is still challenging. The robustness of ALI exposure scenarios is not yet well understood, but critical for the potential standardization of these methods. We report a cause-and-effect (C&E) analysis of a flow through ALI exposure system. The influence of five different instrumental and physiological parameters affecting cell viability and exposure parameters of a human lung cell line in vitro (exposure duration, relative humidity, temperature, CO2 concentration and flow rate) was investigated. After exposing lung epithelia cells to a CeO2 nanoparticle (NP) aerosol, intracellular CeO2 concentrations reached values similar to those found in a recent subacute rat inhalation study in vivo. This is the first study showing that the NP concentration reached in vitro using a flow through ALI system were the same as those in an in vivo study.
Collapse
Affiliation(s)
- Lars B. Leibrock
- German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany; (H.J.); (J.T.); (A.K.); (F.S.B.); (A.V.S.); (P.L.); (A.L.)
| | - Harald Jungnickel
- German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany; (H.J.); (J.T.); (A.K.); (F.S.B.); (A.V.S.); (P.L.); (A.L.)
| | - Jutta Tentschert
- German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany; (H.J.); (J.T.); (A.K.); (F.S.B.); (A.V.S.); (P.L.); (A.L.)
| | - Aaron Katz
- German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany; (H.J.); (J.T.); (A.K.); (F.S.B.); (A.V.S.); (P.L.); (A.L.)
| | - Blaza Toman
- Information Technology Laboratory, National Institute of Standards and Technology, 100 Bureau Drive, Gaitherburg, MD 20899-8311, USA;
| | - Elijah J. Petersen
- Materials Measurement Laboratory, National Institute of Standards and Technology, 100 Bureau Drive, Gaitherburg, MD 20899-8311, USA;
| | - Frank S. Bierkandt
- German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany; (H.J.); (J.T.); (A.K.); (F.S.B.); (A.V.S.); (P.L.); (A.L.)
| | - Ajay Vikram Singh
- German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany; (H.J.); (J.T.); (A.K.); (F.S.B.); (A.V.S.); (P.L.); (A.L.)
| | - Peter Laux
- German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany; (H.J.); (J.T.); (A.K.); (F.S.B.); (A.V.S.); (P.L.); (A.L.)
| | - Andreas Luch
- German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany; (H.J.); (J.T.); (A.K.); (F.S.B.); (A.V.S.); (P.L.); (A.L.)
| |
Collapse
|
28
|
Miller MR, Poland CA. Nanotoxicology: The Need for a Human Touch? SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2020; 16:e2001516. [PMID: 32697439 DOI: 10.1002/smll.202001516] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/08/2020] [Revised: 04/28/2020] [Indexed: 06/11/2023]
Abstract
With the ever-expanding number of manufactured nanomaterials (MNMs) under development there is a vital need for nanotoxicology studies that test the potential for MNMs to cause harm to health. An extensive body of work in cell cultures and animal models is vital to understanding the physicochemical characteristics of MNMs and the biological mechanisms that underlie any detrimental actions to cells and organs. In human subjects, exposure monitoring is combined with measurement of selected health parameters in small panel studies, especially in occupational settings. However, the availability of further in vivo human data would greatly assist the risk assessment of MNMs. Here, the potential for controlled inhalation exposures of MNMs in human subjects is discussed. Controlled exposures to carbon, gold, aluminum, and zinc nanoparticles in humans have already set a precedence to demonstrate the feasibility of this approach. These studies have provided considerable insight into the potential (or not) of nanoparticles to induce inflammation, alter lung function, affect the vasculature, reach the systemic circulation, and accumulate in other organs. The need for further controlled exposures of MNMs in human volunteers - to establish no-effect limits, biological mechanisms, and provide vital data for the risk assessment of MNMs - is advocated.
Collapse
Affiliation(s)
- Mark R Miller
- University/BHF Centre for Cardiovascular Science, University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK
| | - Craig A Poland
- Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK
| |
Collapse
|
29
|
Suhendra E, Chang CH, Hou WC, Hsieh YC. A Review on the Environmental Fate Models for Predicting the Distribution of Engineered Nanomaterials in Surface Waters. Int J Mol Sci 2020; 21:ijms21124554. [PMID: 32604975 PMCID: PMC7349326 DOI: 10.3390/ijms21124554] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2020] [Revised: 06/14/2020] [Accepted: 06/16/2020] [Indexed: 11/16/2022] Open
Abstract
Exposure assessment is a key component in the risk assessment of engineered nanomaterials (ENMs). While direct and quantitative measurements of ENMs in complex environmental matrices remain challenging, environmental fate models (EFMs) can be used alternatively for estimating ENMs' distributions in the environment. This review describes and assesses the development and capability of EFMs, focusing on surface waters. Our review finds that current engineered nanomaterial (ENM) exposure models can be largely classified into three types: material flow analysis models (MFAMs), multimedia compartmental models (MCMs), and spatial river/watershed models (SRWMs). MFAMs, which is already used to derive predicted environmental concentrations (PECs), can be used to estimate the releases of ENMs as inputs to EFMs. Both MCMs and SRWMs belong to EFMs. MCMs are spatially and/or temporally averaged models, which describe ENM fate processes as intermedia transfer of well-mixed environmental compartments. SRWMs are spatiotemporally resolved models, which consider the variability in watershed and/or stream hydrology, morphology, and sediment transport of river networks. As the foundation of EFMs, we also review the existing and emerging ENM fate processes and their inclusion in recent EFMs. We find that while ENM fate processes, such as heteroaggregation and dissolution, are commonly included in current EFMs, few models consider photoreaction and sulfidation, evaluation of the relative importance of fate processes, and the fate of weathered/transformed ENMs. We conclude the review by identifying the opportunities and challenges in using EFMs for ENMs.
Collapse
|